MLSS (STOCKS)
Milestone Scientific, Inc. Common Stock
$0.295300
+0.020200 (+7.34%)
Prev close: $0.275100
Company Information
- Exchange
- XASE
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Eric C Hines
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $23.15M
- Employees
- 17
- P/E (TTM)
- -3.93
- P/B (TTM)
- 7.87
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $8.97M |
| Benefits Costs and Expenses | $14.70M |
| Cost Of Revenue | $2.57M |
| Costs And Expenses | $14.70M |
| Gross Profit | $6.41M |
| Operating Expenses | $12.10M |
| Selling, General, and Administrative Expenses | $11.58M |
| Depreciation and Amortization | $78.20K |
| Research and Development | $449.47K |
| Operating Income/Loss | -$5.70M |
| Income/Loss From Continuing Operations After Tax | -$5.72M |
| Income/Loss From Continuing Operations Before Tax | -$5.72M |
| Net Income/Loss | -$5.72M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$5.72M |
| Net Income/Loss Available To Common Stockholders, Basic | -$5.72M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.07 |
| Diluted Earnings Per Share | -$0.07 |
| Basic Average Shares | 82,064,109 |
| Diluted Average Shares | 82,064,109 |
| Assets | $7.81M |
| Current Assets | $7.48M |
| Inventory | $3.78M |
| Other Current Assets | $3.70M |
| Noncurrent Assets | $328.60K |
| Fixed Assets | $19.19K |
| Intangible Assets | $79.06K |
| Other Non-current Assets | $230.34K |
| Liabilities | $4.99M |
| Current Liabilities | $4.13M |
| Noncurrent Liabilities | $862.54K |
| Equity | $2.81M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $2.81M |
| Liabilities And Equity | $7.81M |
| Net Cash Flow From Operating Activities | -$2.92M |
| Net Cash Flow From Operating Activities, Continuing | -$2.92M |
| Net Cash Flow From Investing Activities | -$15.12K |
| Net Cash Flow From Investing Activities, Continuing | -$15.12K |
| Net Cash Flow From Financing Activities | $786.34K |
| Net Cash Flow From Financing Activities, Continuing | $786.34K |
| Net Cash Flow | -$2.15M |
| Net Cash Flow, Continuing | -$2.15M |
| Comprehensive Income/Loss | -$5.72M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$5.72M |
| Other Comprehensive Income/Loss | $0.00 |